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Predictors of Exercise-Induced 
Pulmonary Hypertension in 
Patients with Asymptomatic 
Degenerative Mitral Regurgitation: 
Mechanistic Insights from 2D 
Speckle-Tracking Echocardiography
Ryo Kamijima, Kengo Suzuki, Masaki Izumo, Shingo Kuwata, Kei Mizukoshi, Manabu Takai, 
Seisyou Kou, Akio Hayashi, Keisuke Kida, Tomoo Harada & Yoshihiro J. Akashi
Presence of exercise-induced pulmonary hypertension (EIPH) in asymptomatic degenerative mitral 
regurgitation (DMR) determines prognosis. This study aimed to elucidate the mechanism and 
predictors of EIPH in asymptomatic DMR. Ninety-one consecutive asymptomatic patients with DMR 
who underwent exercise stress echocardiography were prospectively included. We obtained various 
conventional echocardiographic parameters at rest and during peak exercise, as well as left atrial (LA) 
function at rest using 2-dimensional speckle-tracking analysis. The 25 patients (33.3%) with EIPH were 
significantly older and had a greater ratio of mitral peak velocity of early filling to early diastolic mitral 
annular velocity during peak exercise than those without EIPH. LA strain (LAS)-s and LAS-e, indices 
of LA reservoir and conduit function, respectively, were significantly lower in those with EIPH than in 
those without EIPH. Multivariate analysis indicated that LAS-s was the only resting echocardiographic 
parameter that independently predicted EIPH, with a cut-off value of 26.9%. Furthermore, Kaplan-
Meier curve analysis showed that symptom-free survival was markedly lower among those with reduced 
LAS-s. In conclusion, decreased LA reservoir function contributes to EIPH, and LAS-s at rest is a useful 
indicator for predicting EIPH in asymptomatic patients with DMR.
Mitral valve (MV) prolapse (MVP) is a common disorder affecting 2 to 3% of the general population1,2. Even 
among patients with severe degenerative mitral regurgitation (DMR), determining optimal timing of surgical 
treatment is extremely difficult and controversial. Current guidelines recommend MV surgery based on symp-
tomatic status3,4. However, the postoperative prognosis of DMR depends heavily on presence and extent of 
preoperative symptoms; prognosis worsens after surgery while a patient is symptomatic compared with while 
asymptomatic5,6. In other words, it is essential to predict development of symptoms and perform surgery while 
patients are still asymptomatic, and exercise stress tests have been considered useful in predicting development 
of symptoms.
Among asymptomatic patients with DMR, it has been reported that symptom-free survival is extremely poor 
in those exhibiting exercise-induced pulmonary hypertension (EIPH)7. Various factors have been reported as 
possible mechanisms of pulmonary hypertension (PH) onset in patients with mitral regurgitation (MR), includ-
ing elevated left ventricular (LV) end-diastolic pressure due to systolic and diastolic dysfunction, elevated left 
atrial (LA) pressure due to decreased LA compliance, alveolar capillary stress failure, dysfunctional vascular 
smooth muscle reactivity, distal pulmonary arteriolar hypertrophy, and neointimal proliferation8. However, it 
remains unclear which of these factors contributes most to occurrence of EIPH. Furthermore, facilities that can 
perform exercise echocardiography are limited by issues related to cost and equipment. Hence, the ability to 
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predict EIPH at rest has important clinical implications. Here, we focused on the left atrium because LA function 
has been reported as a prognostic factor in various diseases in recent studies9–15. Therefore, the aim of the present 
study was to elucidate the mechanism and echocardiographic predictors of EIPH in asymptomatic DMR.
Methods
Study subjects. In this prospective study, we recruited 91 consecutive asymptomatic patients with DMR 
with maintained LV systolic function (LV end-systolic diameter < 45 mm and LV ejection fraction [LVEF] > 60%) 
and moderate or greater MR (effective regurgitant orifice area (EROA) > 0.20 cm2 or regurgitant volume [RV] > 
30 mL) who underwent exercise stress echocardiography at our facility from October 2011 to December 2014. 
When selecting participants, asymptomatic patients were defined as those who did not exhibit specific symptoms 
of heart failure with a New York Heart Association functional classification of II or below. Experienced cardiolo-
gists conducted interviews with the patients and confirmed medical history and presence of current symptoms. 
Of these patients, we excluded those with resting PH, defined as pulmonary artery systolic pressure (PASP) ≥ 
50 mmHg according to guidelines3 (n = 2); combined valvular heart disease, such as mitral stenosis and aortic 
valve disease (n = 3); persistent atrial fibrillation (n = 4); those in whom enforcement of exercise proved difficult 
(n = 3); and those whose imaging results could not be analyzed due to poor image quality (n = 4). Ultimately, 75 
patients were registered.
Conventional echocardiography. Echocardiography was performed in the left lateral decubitus posi-
tion using a commercially available system (Vivid E9; GE Vingmed, Milwaukee, WI, USA). Images were 
obtained using a 3.5-MHz transducer in the parasternal and apical views (long-axis, 2- and 4-chamber views). 
Two-dimensional echocardiography measured each chamber’s dimension, volume, and wall thickness according 
to the recommendations of the American Society of Echocardiography16. LVEF was calculated according to the 
biplane Simpson’s method in apical 2 and 4-chamber views. Ratio of early (E) to late (A) transmitral velocities 
(E/A) and deceleration time of E velocity were obtained using pulsed-wave Doppler in the apical 4-chamber view. 
E’ was measured at the septal mitral annulus in the apical 4-chamber view by placing the sample volume at a sam-
ple size of 8 mm. The ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (E’) 
(E/E’) was measured to estimate LV filling pressure17. MR severity was measured using the doppler volumetric 
method18 and proximal isovelocity surface area method19. When both methods could be obtained, the results 
were averaged, both at rest and during peak exercise. Stroke volume (SV) was calculated by multiplying LV out-
flow tract (LVOT) area by LVOT velocity-time integral measured using pulsed-wave doppler. Then, cardiac out-
put (CO) was calculated as SV × heart rate. PASP was estimated based on the tricuspid regurgitation jet according 
to the simplified Bernoulli equation (PASP = 4 × v2 + right atrial pressure), in which “v” is peak velocity of the 
tricuspid regurgitation jet (m/s), and right atrial pressure is estimated from the diameter and breath-induced 
variability of the inferior vena cava20. These conventional echocardiographic parameters were collected at rest and 
during peak exercise, respectively.
2D speckle-tracking analysis. LA strain (LAS) and LA strain rate (LASR) were assessed using 2-dimensional 
(2D) speckle-tracking analysis with QRS onset as the reference point by applying a commercially available LV 
strain software package to the left atrium (EchoPAC, version 12; GE Vingmed, Milwaukee, WI, USA)21. In sum-
mary, the region of interest was adjusted to include the LA myocardium in the apical 4- and 2-chamber views that 
included both the left atrium and left ventricle. Manual correction was performed to optimize tracking results, if 
needed. LAS and LASR were calculated as the average value of the 4- and 2-chamber views, as described in Fig. 1. 
As previously reported, LA reservoir function was calculated as peak systolic LAS-s, whereas LA contractile 
function (LAS-e) was measured as LAS at QRS wave onset on electrocardiography. Finally, LA conduit function 
(LAS-a) was assessed as the difference between LAS-s and LAS-e. In addition, LASR-s was measured as the peak 
systolic positive value; LASR-e, as the early diastolic negative peak value; and LASR-a, as the late diastolic nega-
tive peak value. For simplicity, absolute deformation values are reported as positive numbers22. In this study, we 
obtained LA function using 2D speckle-tracking analysis at rest only. In addition, the relationship between LA 
size and function was evaluated, with LA enlargement defined as LA diameter (LAD) ≥ 55 mm or LA volume 
index (LAVI) ≥ 60 mL/m2, similar to a previous study23.
Exercise echocardiography. All patients underwent echocardiography at rest to collect conventional 
parameters. Then, they also underwent a symptom-limited graded cycle ergometer exercise test in a semisupine 
position on a tilting exercise table (ergometer and tilt table 750EC; Lode) for continuous 2D echocardiography. 
After a 3-min workload at 25 watts (W), intensity was increased by 25 W every 3 min. The obtained data were 
stored digitally. Electrocardiograms, blood pressure, and heart rate were recorded every min. According to guide-
lines3, EIPH was defined as PASP ≥ 60 mmHg. Criteria for halting the test were development of chest pain, severe 
dyspnea, severe fatigue, a sustained blood pressure drop, sustained ventricular tachycardia, short runs of 3 or 
more ventricular premature contractions, pallor, and/or dizziness.
Symptom-free survival. Follow-up was performed according to current guidelines3,4. Patients were clas-
sified as symptomatic when shortness of breath, dizziness, or syncope with exertion was identified during the 
follow-up period of 44 ± 21 months. Physical examination and echocardiography were performed by experienced 
cardiologists, and symptomatic status was carefully assessed.
Statistical analysis. Continuous variables are presented as mean ± standard deviation (SD), while categori-
cal variables are presented as number (percentage). The unpaired Student’s t test and χ 2 test were used to compare 
variables between the EIPH and non-EIPH groups, as determined by exercise PASP. Associations of exercise 
PASP with several conventional echocardiographic parameters were investigated using Pearson’s correlation 
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analysis. Multiple linear regression analysis was performed to evaluate the associations of exercise PASP with 
clinical and echocardiographic parameters at rest and peak exercise. Factors found to be significant in uni- and 
multivariate analyses were evaluated using receiver operating characteristic (ROC) curves. Then, sensitivity, spec-
ificity, positive predictive value, and negative predictive value for predicting occurrence of EIPH were determined 
Figure 1. (a) Four-chamber left atrial strains (LASs). (b) Four-chamber LAS rates (LASRs). The white dotted 
line represents the mean value of the tracked LA segments. Reservoir (r), conduit (e), and contractile (a) strains 
are represented by color-coded arrows (yellow, pink, and blue, respectively). Measurements were averaged over 
4- and 2-chamber views. In this patient, reservoir, conduit, and contractile strains and strain rates were 41.1%, 
− 25.6%, and − 15.5%, and 1.68 s−1, − 2.0 s−1, and − 2.2 s−1, respectively.
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for various cut-off values. Kaplan-Meier curves were constructed to explore differences in symptom-free survival 
among patient subgroups, stratified according to presence of EIPH or LAS using the ROC curve–based cut-off 
value, and compared using the log-rank test. Statistical analyses were performed using JMP 10 (SAS Institute Inc., 
Cary, NC, USA), with statistical significance set at P < 0.05.
The authors had full access to and took full responsibility for the integrity of the data. All authors have read 
and agree to the manuscript as written.
Ethics. This study was performed in accordance with the ethical principles set forth in the Declaration 
of Helsinki, and the study protocol was approved by the Institutional Committee on Human Research of St. 
Marianna University School of Medicine, Kanagawa, Japan (No. 1288). Written informed consent was obtained 
from all patients prior to their enrollment.
Results
Patient characteristics and echocardiographic parameters. Patients’ clinical features are shown in 
Table 1. Mean age was 59.1 ± 13.1 years, and 74.7% were men. Anterior and posterior leaflet prolapse were con-
firmed in 29.3% and 64.0% of patients, respectively. Of the study patients, 25 (33.3%) were assigned to the EIPH 
group. Although there were no significant differences between groups in terms of sex, body mass index, heart rate, 
blood pressure, or log of brain natriuretic peptide concentration, the EIPH group was significantly older than the 
non-EIPH group (64.0 ± 11.2 years vs. 56.6 ± 13.4 years, P = 0.01). In addition, as hypertension was more preva-
lent in the EIPH group, introduction of calcium channel–blocking oral medication was significantly higher in the 
EIPH group (44.0% vs. 12.0%, P = 0.002). Causes of MR were similar between groups. Echocardiographic data at 
rest and during exercise are displayed in Table 2. EROA and RV were 0.41 ± 0.12 cm2 and 62.0 ± 18.1 mL, respec-
tively. We found no differences in conventional echocardiographic parameters at rest between groups. During 
exercise, LVEF increased significantly (+ 5.9% ± 0.8%, P < 0.001). As expected, LV stroke volume and cardiac 
output also increased significantly from rest to peak exercise (+ 3.5 ± 1.1 mL, P = 0.002; + 4.1 ± 0.2 L, P < 0.001, 
respectively). Similarly, EROA also increased from rest to peak exercise (+ 0.08 ± 0.01 mm2, P < 0.001). Twenty-
seven (67.5%) of 40 patients with moderate MR developed severe MR by exercise. However, no differences in 
MR severity, SV, or CO during exercise were observed between groups. On the other hand, the EIPH group had a 
significantly higher E/E’ than the non-EIPH group (13.7 ± 4.6 vs. 11.1 ± 3.4, P = 0.01).
LA volume and function. Various LA measurement values are displayed in Table 3. The groups did not 
differ significantly with regard to LAD or LAVI. However, LAS-s, LASR-s, LAS-e, and LASR-e were significantly 
All patients (n = 75) Non-EIPH (n = 50, 66.7%) EIPH (n = 25, 33.3%) P value
Clinical characteristics
 Age, y 59.1 ± 13.1 56.6 ± 13.4 64.0 ± 11.2 0.01
 Male sex 56 (74.7) 37 (74.0) 19 (76.0) 0.85
 BMI, kg/m2 22.2 ± 3.2 21.9 ± 3.3 22.7 ± 3.2 0.33
 Heart rate, bpm 69.5 ± 10.9 69.0 ± 11.5 70.6 ± 9.8 0.54
 SBP, mmHg 132.7 ± 17.1 130.6 ± 14.3 136.9 ± 21.3 0.16
 DBP, mmHg 74.3 ± 10.1 74.0 ± 9.8 74.7 ± 10.8 0.72
 Log BNP, pg/mL 1.49 ± 0.32 1.46 ± 0.29 1.53 ± 0.37 0.31
Risk factors
 Hypertension 31 (41.3) 16 (32.0) 15 (60.0) 0.02
 Dyslipidemia 14 (18.7) 10 (20.0) 4 (16.0) 0.68
 Diabetes mellitus 0 (0) 0 (0) 0 (0) -
Medications
 ACE-I/ARB 20 (26.7) 10 (20.0) 10 (40.0) 0.06
 β -blocker 6 (8.0) 2 (4.0) 4 (16.0) 0.07
 Calcium channel blocker 17 (22.7) 6 (12.0) 11 (44.0) 0.002
 Diuretic 13 (17.3) 6 (12.0) 7 (28.0) 0.08
 Statin 10 (13.3) 7 (14.0) 3 (12.0) 0.81
Etiology of mitral regurgitation
 Anterior leaflet prolapse 22 (29.3) 16 (32.0) 6 (24.0) 0.47
 Posterior leaflet prolapse 48 (64.0) 31 (62.0) 17 (68.0) 0.61
 Both leaflet prolapse 2 (2.7) 1 (2.0) 1 (4.0) 0.61
 Sclerotic change 3 (4.0) 2 (4.0) 1 (4.0) 1.00
Table 1.  Baseline characteristics. Data are expressed as mean ± SD or number (percentage), as appropriate. 
Abbreviations: ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body 
mass index; BNP, brain natriuretic peptide; DBP, diastolic blood pressure; EIPH, exercise-induced pulmonary 
hypertension; SBP, systolic blood pressure.
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lower in the EIPH group (LAS-s: 22.9 ± 5.5 vs. 32.4 ± 6.8, P < 0.001; LASR-s: 1.11 ± 0.26 vs. 1.42 ± 0.33, P < 0.001; 
LAS-e: 14.8 ± 5.4 vs. 19.9 ± 6.8, P = 0.003; LASR-e: 1.13 ± 0.29 vs. 1.36 ± 0.36, P = 0.003).
All patients (n = 75) Non-EIPH (n = 50, 66.7%) EIPH (n = 25, 33.3%) P value
Resting
 LVESVI, mL/m2 27.0 ± 6.4 27.9 ± 6.7 25.4 ± 5.6 0.14
 LVEDVI, mL/m2 81.1 ± 17.8 82.1 ± 18.3 79.1 ± 17.0 0.54
 LVEF, % 67.6 ± 4.7 67.1 ± 4.7 68.6 ± 4.6 0.16
 E-wave velocity, cm/s 105.5 ± 27.4 101.2 ± 24.4 114.2 ± 31.3 0.11
 A-wave velocity, cm/s 67.2 ± 16.9 64.9 ± 16.2 72.0 ± 17.6 0.07
 E/A ratio 1.66 ± 0.60 1.69 ± 0.62 1.59 ± 0.56 0.48
 E/E’ 11.5 ± 3.6 11.1 ± 3.4 12.4 ± 3.9 0.09
 LAVI, mL/m2 54.2 ± 18.9 52.8 ± 18.9 56.9 ± 18.8 0.36
 Severe MR 35 (46.7) 22 (44.0) 13 (52.0) 0.51
 EROA, mm2 0.41 ± 0.12 0.41 ± 0.13 0.42 ± 0.11 0.57
 Regurgitant volume, mL 62.0 ± 18.1 61.6 ± 19.6 62.9 ± 14.8 0.53
 PASP, mmHg 28.8 ± 4.4 28.1 ± 4.1 30.1 ± 4.7 0.09
 Stroke volume, mL 59.0 ± 12.4 60.2 ± 12.0 56.7 ± 13.0 0.28
 Cardiac output, L 4.05 ± 0.90 4.10 ± 0.97 3.94 ± 0.77 0.65
Peak exercise
 LVESVI, mL/m2 24.8 ± 6.3 24.5 ± 6.0 25.4 ± 7.0 0.88
 LVEDVI, mL/m2 84.0 ± 16.5 82.2 ± 18.0 85.4 ± 13.3 0.58
 LVEF, % 70.6 ± 5.0 70.3 ± 4.9 71.3 ± 5.2 0.45
 E-wave velocity, cm/s 144.0 ± 27.1 140.2 ± 28.8 151.4 ± 22.1 0.11
 A-wave velocity, cm/s 110.9 ± 25.8 108.1 ± 27.9 116.6 ± 20.2 0.34
 E/A ratio 1.36 ± 0.45 1.35 ± 0.50 1.38 ± 0.27 0.40
 E/E’ 12.0 ± 4.0 11.1 ± 3.4 13.7 ± 4.6 0.01
 LAVI, mL/m2 49.5 ± 17.8 48.4 ± 17.9 51.8 ± 17.8 0.43
 Severe MR 58 (77.3) 36 (72.0) 22 (88.0) 0.12
 EROA, mm2 0.49 ± 0.17 0.48 ± 0.18 0.51 ± 0.16 0.21
 Regurgitant volume, mL 65.9 ± 15.9 63.9 ± 18.0 66.3 ± 10.5 0.09
 PASP, mmHg 48.8 ± 12.5 41.4 ± 8.2 63.3 ± 3.6 < 0.001
 Stroke volume, mL 62.6 ± 14.1 64.3 ± 13.7 59.3 ± 14.5 0.20
 Cardiac output, L 7.71 ± 1.94 7.77 ± 1.83 7.59 ± 2.19 0.80
Delta (peak exercise – resting)
 Δ EROA, mm2 0.11 ± 0.13 0.09 ± 0.14 0.13 ± 0.08 0.06
 Δ Regurgitant volume, mL 6.0 ± 14.2 4.9 ± 15.3 8.2 ± 11.9 0.35
 Δ Stroke volume, mL 3.5 ± 9.3 3.9 ± 10.1 2.6 ± 7.8 0.96
 Δ Cardiac output, L 3.66 ± 1.6 3.66 ± 1.54 3.65 ± 1.77 0.99
Table 2.  Resting and exercise echocardiographic data. Data are expressed as mean ± SD or number 
(percentage), as appropriate. Abbreviations: EIPH, exercise-induced pulmonary hypertension; EROA, effective 
regurgitant orifice area; LAVI, left atrial volume index; LVEDVI, left ventricular end-diastolic volume index; 
LVEF, left ventricular ejection fraction; LVESVI, left ventricular end-systolic volume index; MR, mitral 
regurgitation; PASP, pulmonary artery systolic pressure.
All patients (n = 75) Non-EIPH (n = 50, 66.7%) EIPH (n = 25, 33.3%) P value
LAD, mm 40.9 ± 6.9 39.9 ± 7.2 42.7 ± 5.9 0.08
LAVI, mL/m2 54.2 ± 18.9 52.8 ± 18.9 56.9 ± 18.8 0.36
LAS-s, % 29.2 ± 7.8 32.4 ± 6.8 22.9 ± 5.5 < 0.001
LAS-e, % 18.2 ± 6.8 19.9 ± 6.8 14.8 ± 5.4 0.003
LAS-a, % 10.9 ± 4.8 11.7 ± 5.0 9.3 ± 4.1 0.05
LASR-s, s−1 1.32 ± 0.34 1.42 ± 0.33 1.11 ± 0.26 < 0.001
LASR-e, s−1 1.29 ± 0.36 1.36 ± 0.36 1.13 ± 0.29 0.003
LASR-a, s−1 1.30 ± 0.35 1.35 ± 0.39 1.18 ± 0.23 0.07
Table 3.  Echocardiographic data on left atrial volume and function at rest. Data are expressed as 
mean ± SD. Abbreviations: EIPH, exercise-induced pulmonary hypertension; LAD, left atrial diameter; LAS, 
left atrial strain; LASR, left atrial strain rate; LAVI, left atrial volume index.
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In addition, there was a negative correlation between LA function and LA size. However, LA function was 
decreased in several cases despite absence of LA enlargement (32/72 [44%] with LAD < 55 mm; 14/48 [29%] with 
LAVI < 60 mL/m2) (Fig. 2). There were also cases in which LA function differed despite equivalent LAVI (Fig. 3).
Correlations with pulmonary artery systolic pressure during peak exercise. Pulmonary artery 
systolic pressure (PASP) during peak exercise was correlated with age, resting PASP, LAS-s, LAS-e, LASR-s, 
LASR-e, and E/E’ during peak exercise. There was no significant correlation between MR severity and PASP 
either at rest or during peak exercise. Similarly, SV and CO were not associated with PASP during peak exercise 
(Table 4). Multivariate linear regression analysis indicated that age (coefficient, 0.167; 95% confidence interval 
[CI], 0.029–0.363, P = 0.031) and LAS-s (coefficient, − 0.792; 95% CI, − 0.988 to − 0.444, P < 0.001) were inde-
pendent factors associated with PASP during peak exercise (R2 = 0.44, P < 0.001) (Table 5). Similar results were 
found in the multivariable analyses using LASR-s instead of LAS-s. Accordingly, LASR-s was also a statistically 
significant echocardiographic parameter. However, the measurement of strain rate based on the speckle tracking 
method has difficulties and poor reproducibility due to relative noise than strain; thus, this study employed strain, 
as well as the earlier conducted studies, which is clinically useful. Thus, LAS-s was the useful resting echocardio-
graphic parameter that independently predicted PASP during peak exercise.
LA function predicts EIPH. In ROC analysis, LAS-s, an index of reservoir function, had an area under the 
curve of 0.85, and predicted EIPH with higher accuracy than age. Its optimal cut-off value was 26.9% (sensitivity, 
80%; specificity, 74%) (Fig. 4).
Relationship between LA function and prognosis. Follow-up was complete in 75 patients (100%), 
with a mean follow-up period of 44 ± 21 months. During follow-up, 46 patients (61%) remained asymptomatic 
and 29 (39%) developed symptoms. Six patients were hospitalized for congestive heart failure, 4 developed new 
onset atrial fibrillation, and 3 developed resting PH. MV surgery was performed in 22 patients: 3 underwent MV 
replacement and 19 underwent MV repair. All patients underwent surgery because of symptoms. There was no 
perioperative mortality.
Based on ROC analysis, all patients were divided into a preserved LAS-s group (LAS-s > 26.9%) and a reduced 
LAS-s group (LAS-s ≤ 26.9%). During follow-up, symptom-free survival was markedly lower in the reduced 
LAS-s group (log-rank P < 0.01, Fig. 5). Thus, decreased LA reservoir function was a predictor of EIPH and a 
useful predictor of prognosis.
Discussion
The major findings of this study are as follows: First, EIPH occurred in approximately 35% of asymptomatic 
patients with DMR. Second, LA functional indices using strain analysis are resting indices that can predict EIPH 
onset. Third, LAS-s, an index of reservoir function, stratified prognosis in asymptomatic DMR.
As aforementioned, the mechanisms of PH onset in MR are manifold8. Although this study did not exam-
ine pathologic aspects, such as alveolar capillary stress failure, dysfunctional vascular smooth muscle reactivity, 
and thickening and intimal hyperplasia of the distal pulmonary arterioles, we found that LA function contrib-
uted most to EIPH, even more so than LV contractile and diastolic dysfunction. In a previous study, Magne 
et al. demonstrated a relationship between MR severity and EIPH7, but there was no such correlation in the 
current study. This may be because, in comparison to our study, theirs included more severe cases of MR (RV, 
62.0 ± 18.1 mL vs. 71 ± 27 mL). We believe this also contributed to the 48-month event-free survival in the EIPH 
group in their study, which was roughly 15% and lower than the estimated 40% found in our study. Because this 
study included less severe cases of MR, the decrease in only LAS-s and E/E’ peak exercise in the early stages must 
have been associated with EIPH, without exhibiting differences associated with MR severity.
LA performance consists of 3 functions: reservoir, conduit, and booster pump24. Among these, reservoir dys-
function was most relevant to EIPH. The 2D speckle-tracking method is noninvasive and automatically tracks 
Figure 2. Correlations of left atrial strain (LAS)-s with LA diameter (LAD) and LA volume index (LAVI). 
LAS-s ≤ 26.9% (associated with estimated exercise-induced pulmonary hypertension) was present in 44 and 
29% of patients despite LAD < 55 mm and LAVI < 60 mL/m2, respectively (pink squares).
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specific myocardial speckles systemically; it is a new technique that assesses local or global myocardial move-
ment and speed, and its function25–29. In this study, 2D speckle tracking was applied to the left atrium, and the 
aforementioned LA functions were each classified and assessed with good reproducibility and accuracy21. The 
reservoir phase begins with ventricular systole, during which the mitral annulus and MV descend because of 
longitudinal shortening during LV contraction. LA volume increases while LA pressure decreases because of 
active relaxation of the atrium, and the left atrium receives blood from the pulmonary veins during ventricular 
systole. In other words, LA reservoir function is mainly determined by LA compliance (stiffness) and LV systolic 
function (movement of the LV base towards the ventricular apex)30–32. However, because all subjects in this study 
were required to have preserved LVEF, decreased LA reservoir function is considered to have been primarily due 
to decreased LA compliance rather than LV systolic function. It has been reported that LA reservoir dysfunction 
observed in patients with DMR is caused by ultrastructural changes in the LA myocardium, such as interstitial 
fibrosis, myocyte hypertrophy, chronic inflammatory changes, and decreased capillary density23,33–36. Because MR 
jets flow into the left atrium during ventricular systole, the corresponding reservoir function during that moment 
is critical to patients with MR. The results of the current study also showed that of all LA functions, reservoir 
function most profoundly contributed to EIPH.
LA enlargement resulting from volume overload in DMR influences severity and duration of MR37. The rela-
tionship between LAD and mortality in patients with DMR caused by MVP has been demonstrated in the Mitral 
Regurgitation International Database registry. Cases with LAD ≥ 55 mm showed extremely low 8-year survival, 
and this was an independent predictor of all-cause and cardiovascular mortality38. Furthermore, Le Tourneau 
et al. showed that LA volume played a role in 5-year survival: in patients with LAVI ≥ 60 mL/m2, mortality and 
cardiovascular events were reported to increase39. However, in our study, we did not observe a significant cor-
relation between EIPH and either LAD or LAVI. The left atrium expands as a compensatory change to volume 
overload associated with MR; however, in our study, there were several patients who had LAD ≥ 55 mm (4%) 
or LAVI ≥ 60 mL/m2 (36%). This may have been due to the patients in our study being younger than those in 
previous studies, with shorter MR durations, and our study may have included less severe cases of MR (RV, 
62.0 ± 18.1 mL vs. 68 ± 42 mL). LAS-s has been reported to decrease from moderate stages of MR40; our data 
Figure 3. Although cases 1 and 2 had a similar left atrial volume index (LAVI, approximately 55 mL/
m2), LA function, as indicated by 2D speckle-tracking echocardiography, was significantly different. In 
case 1, reservoir (r), conduit (e), and contractile (a) strains and strain rates were 41.1%, − 25.6%, and − 15.5%, 
and 1.68 s−1, − 2.0 s−1, and − 2.2 s−1, respectively. On the other hand, case 2 had lower reservoir, conduit, 
and contractile strains and strain rates (22.1%, − 13.9%, and − 8.2%, and 1.02 s−1, − 0.70 s−1, and − 0.82 s−1, 
respectively). Abbreviations: LAS, left atrial strain; LASR, left atrial strain rate.
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confirmed this observation even in moderate cases. Additionally, in a previous study, 47 (48%) of 98 patients with 
LAD < 55 mm and 15 (34%) of 44 patients with LAVI < 60 mL/m2 demonstrated LA dysfunction23, similar to the 
results obtained in our study. Although there was certainly a correlation between LA function and size in this 
study, LA reservoir function was considered to acutely influence findings of volume overload in DMR at an earlier 
stage than LA size because such a decline in LA function began to occur earlier than LA enlargement. Therefore, 
evaluation of LA function using 2D speckle tracking can be used to predict EIPH in asymptomatic patients with 
DMR at an earlier stage than LA enlargement.
Variable
Correlation with PASP during peak exercise
R P value
Age 0.38 < 0.001
Resting
 Heart rate 0.03 0.78
 SBP 0.04 0.76
 DBP 0.13 0.28
 LVESVI 0.18 0.12
 LVEDVI 0.14 0.25
 LVEF 0.21 0.07
 E/A ratio 0.12 0.30
 E/E’ 0.23 0.05
 EROA 0.03 0.78
 Regurgitant volume 0.04 0.71
 PASP 0.25 0.03
 Stroke volume 0.16 0.17
 Cardiac output 0.19 0.11
 LAD 0.22 0.06
 LAVI 0.21 0.07
 LAS-s − 0.58 < 0.001
 LAS-e − 0.38 < 0.001
 LAS-a − 0.25 0.03
 LASR-s − 0.47 < 0.001
 LASR-e − 0.39 0.001
 LASR-a − 0.23 0.05
Peak exercise
 Heart rate 0.18 0.13
 SBP 0.16 0.17
 DBP 0.09 0.46
 LVESVI 0.01 0.91
 LVEDVI 0.07 0.57
 LVEF 0.20 0.09
 E/A ratio 0.05 0.68
 E/E’ 0.31 0.01
 EROA 0.10 0.40
 Regurgitant volume 0.20 0.09
 LAD 0.17 0.14
 LAVI 0.15 0.21
 Stroke volume 0.20 0.08
 Cardiac output 0.10 0.42
Delta (peak exercise – resting)
 Δ EROA 0.14 0.22
 Δ Regurgitant volume 0.14 0.23
 Δ Stroke volume 0.09 0.47
 Δ Cardiac output 0.01 0.93
Table 4.  Correlations with PASP during peak exercise. Abbreviations: DBP, diastolic blood pressure; EROA, 
effective regurgitant orifice area; LAD, left atrial diameter; LAS, left atrial strain; LASR, left atrial strain rate; 
LAVI, left atrial volume index; LVEDVI, left ventricular end-diastolic volume index; LVEF, left ventricular 
ejection fraction; LVESVI, left ventricular end-systolic volume index; PASP, pulmonary artery systolic pressure; 
SBP, systolic blood pressure.
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The present study has several limitations. First, our data were taken from a small sample at a single facility. 
Second, we did not assess LA function using 2D speckle-tracking during peak exercise. This was because of a 
technical difficulty: heart rate during peak exercise was too fast, and the LA wall was too thin to track with the 
software used in this study. Third, right atrial pressure, a fundamental aspect of our study, was not constant among 
subjects. Additionally, despite the fact that variation was observed even within the same patient depending on his/
Variable Coefficient 95% CI P value
Age 0.167 0.029 to 0.363 0.031
Resting PASP 0.187 − 0.385 to 0.760 0.516
LAS-s − 0.792 − 0.988 to − 0.444 < 0.001
Peak exercise E/E’ 0.526 − 0.079 to 1.130 0.097
Δ EROA 7.572 − 12.476 to 27.619 0.454
Δ Stroke volume 0.070 − 0.333 to 0.193 0.596
Table 5.  Multiple linear regression analysis to determine PASP during peak exercise. Abbreviations: CI, 
confidence interval; EROA, effective regurgitant orifice area; LAS, left atrial strain; PASP, pulmonary artery 
systolic pressure.
Figure 4. In receiver operating characteristic analysis, left atrial strain (LAS)-s, an index of reservoir 
function, had an area under the curve (AUC) of 0.85 and could predict exercise-induced pulmonary 
hypertension with higher accuracy than age at a cut-off value of 26.9% (sensitivity, 80%; specificity, 74%). 
Figure 5. Symptom-free survival according to left atrial strain (LAS)-s, an index of reservoir function. 
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her condition, right atrial pressure used for PASP calculation in this study was estimated using a semiquantitative 
method involving diameter and respiratory change of the inferior vena cava. Although this estimation was per-
formed in the same manner at rest and during exercise, it is possible that changes in right atrial pressure during 
exercise cannot be accurately recorded using this method. As with other studies, use of noninvasive techniques 
in this study to evaluate right atrial pressure at rest and during exercise has its limitations, and remains a concern.
In conclusion, EIPH occurred in approximately 35% of asymptomatic patients with moderate to advanced 
DMR. LAS-s, an index of LA reservoir function, was the only resting echocardiographic indicator that inde-
pendently predicted EIPH. Furthermore, LAS-s was associated with a decrease in symptom-free survival. Based 
on our results, we propose that evaluation of LA function using 2D speckle tracking is useful for predicting EIPH 
and prognosis in asymptomatic patients with DMR.
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